1Y Close · As of Aug 26, 2026
Binex operates in the Pharmaceuticals sector.
Legal name: Binex Co., Ltd.
In fiscal year 2025, Binex (053030) reported revenue of 168.5 billion KRW, up 29.5% from 130.1 billion KRW a year earlier.
Operating profit was -4.5 billion KRW and net income was -3.3 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 237.9 billion KRW, with a P/B of 1.27.
These figures can be verified in the DART filing (receipt no. 20260313001124).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 168.5B | -4.5B | -3.3B |
| 2024 | 130.1B | -30.8B | -35.2B |
| 2023 | 154.8B | 1.0B | 4.6B |
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-07-31 | Large Shareholding Report (General) |